US80105N1054 - ADR
SANOFI-ADR
NASDAQ:SNY (3/28/2024, 8:00:02 PM)
After market: 48.25 -0.35 (-0.72%)48.6
-0.94 (-1.9%)
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 91,573 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.
SANOFI-ADR
46 Avenue de la Grande Armee
Paris ILE-DE-FRANCE 75008
P: 33153774000
CEO: Paul Hudson
Employees: 91573
Website: https://www.sanofi.com/
With the Fear and Greed Index at 69, it's an opportune to wager on these attractive Stocks with Moonshot Potential.
With certain sectors in the domestic market appearing overstretched, these global growth stocks may offer better opportunities.
Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising.
With uncertainty again weighing on the market, investors can take shelter under these cash cow dividend stocks.
Here you can normally see the latest stock twits on SNY, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: